Samuel B. Barone serves as Executive at Avalanche Biotechnologies, Inc., where they oversee executive responsibilities. Since joining the company, Samuel B. Barone has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 9, 2017 involved receiving (via award) 58,000 shares valued at $0.
Samuel B. Barone currently holds 172,335 shares of Avalanche Biotechnologies, Inc. (AAVL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samuel B. Barone has been a net neutral trader of AAVL stock. They have purchased $0 and sold $0 worth of shares.
Samuel B. Barone's most recent insider trade was on Feb 9, 2017, when they sold 58,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 12, 2016 | AAVL | $0 | Award | 50,000 | $N/A | Discretionary |
| Aug 21, 2015 | AAVL | $0 | Award | 33,960 | $N/A | Discretionary |
| Apr 21, 2015 | AAVL | $0 | Award | 7,000 | $N/A | Discretionary |